{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:31:42Z","timestamp":1761093102568,"version":"build-2065373602"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,7,16]],"date-time":"2002-07-16T00:00:00Z","timestamp":1026777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["pathsocjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pathology"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The plasminogen activation (PA) system is involved in the process of invasion and metastasis. Its major components are urokinase (uPA) and tissue\u2010type plasminogen activator (tPA), plasminogen activation inhibitor type 1 and 2 (PAI\u20101 and PAI\u20102) and a receptor for urokinase (uPAR). In this study, the expression of plasminogen activation components in Spitz naevi was compared with that in common and dysplastic naevi on the one hand and primary cutaneous melanomas on the other. Spitz naevi had melanocytic positivity for uPA in 0% (0\/36), tPA in 30% (6\/20), PAI\u20101 in 10% (3\/35), PAI\u20102 in 40% (8\/21) and uPAR in 60% (13\/21) of cases. This far exceeded the expression found in common (<jats:italic>n<\/jats:italic> = 25) and dysplastic (<jats:italic>n<\/jats:italic> = 15) naevi, which only showed melanocytic positivity for PAI\u20102 (20% and 15% respectively) and in one dysplastic naevus also for uPAR. This was much (for most components significantly) less than the proportion of primary melanomas with tumour cell positivity, which was 30% (11\/38) for uPA, 80% (19\/24) for tPA, 75% (28\/38) for PAI\u20101, 80% (19\/24) for PAI\u20102 and 80% (19\/24) for uPAR. The main findings of this study are that Spitz naevi, firstly, may express plasminogen activator (tPA), inhibitors and the receptor of the PA system, but in a much smaller proportion than cutaneous melanomas; and secondly, do not express urokinase, whereas some of the melanomas do. uPA positivity may therefore be suggestive of melanoma. However, overlapping staining results imply that the PA system has limited value in the differential diagnosis between Spitz naevus and primary melanoma. As serine protease components are expressed, Spitz naevi may use this proteolytic machinery to accomplish matrix degradation, although in a more restricted, possibly transient manner than melanomas. Copyright \u00a9 2002 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/path.1167","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T08:04:53Z","timestamp":1033891493000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Spitz naevi may express components of the plasminogen activation system"],"prefix":"10.1002","volume":"198","author":[{"given":"Cilia M.","family":"Ferrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winny L.","family":"van Geloof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huub","family":"Straatman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred J. J. M.","family":"van de Molengraft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goos N. P.","family":"van Muijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"Ruiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,7,16]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1986.tb02572.x"},{"key":"e_1_2_6_3_2","first-page":"36","article-title":"The histology and differential diagnosis of Spitz nevus","volume":"10","author":"Binder SW","year":"1993","journal-title":"Diagn Pathol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951115)76:10<1833::AID-CNCR2820761024>3.0.CO;2-L"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1997.tb01091.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<266::AID-PATH812>3.0.CO;2-#"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(98)90421-X"},{"key":"e_1_2_6_8_2","first-page":"893","article-title":"Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)","volume":"13","author":"Reuning U","year":"1998","journal-title":"Int J Oncol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000468617"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(97)80126-3"},{"key":"e_1_2_6_11_2","first-page":"841","article-title":"Content and characterization of plasminogen activators in human lung tumors and normal lung tissue","volume":"40","author":"Markus G","year":"1980","journal-title":"Cancer Res"},{"key":"e_1_2_6_12_2","first-page":"311","article-title":"Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues","volume":"44","author":"Camiolo SM","year":"1984","journal-title":"Cancer Res"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240530206"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1079::AID-CNCR12>3.0.CO;2-Z"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1979.tb01123.x"},{"key":"e_1_2_6_16_2","first-page":"4547","article-title":"Plasminogen activation in melanocytic neoplasia","volume":"54","author":"Delbaldo C","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199604000-00001"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853899809002484"},{"key":"e_1_2_6_19_2","first-page":"70","article-title":"Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression","volume":"144","author":"de Vries TJ","year":"1994","journal-title":"Am J Pathol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(05)80419-8"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/002215549804600406"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/172460089701200102"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00665944"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.1994.tb00025.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65023-7"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0012-1606(73)90337-0"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/physzool.20.3.30151958"},{"key":"e_1_2_6_28_2","first-page":"1953","article-title":"CD40 is a prognostic marker in primary cutaneous malignant melanoma","volume":"149","author":"van den Oord JJ","year":"1996","journal-title":"Am J Pathol"},{"key":"e_1_2_6_29_2","first-page":"1549","article-title":"MAGE\u20103 immunoreactivity in formalin\u2010fixed, paraffin\u2010embedded primary and metastatic melanoma: frequency and distribution","volume":"151","author":"Hofbauer GFL","year":"1997","journal-title":"Am J Pathol"},{"key":"e_1_2_6_30_2","first-page":"917","article-title":"Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas","volume":"10","author":"Kanter\u2010Lewensohn L","year":"1997","journal-title":"Mod Pathol"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880040"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(98)90418-X"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199512000-00003"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199612000-00003"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711730305"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199604000-00006"}],"container-title":["The Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpath.1167","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/path.1167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:37:22Z","timestamp":1761043042000},"score":1,"resource":{"primary":{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/10.1002\/path.1167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,16]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1002\/path.1167"],"URL":"https:\/\/doi.org\/10.1002\/path.1167","archive":["Portico"],"relation":{},"ISSN":["0022-3417","1096-9896"],"issn-type":[{"type":"print","value":"0022-3417"},{"type":"electronic","value":"1096-9896"}],"subject":[],"published":{"date-parts":[[2002,7,16]]},"assertion":[{"value":"2001-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-04-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-07-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}